De-risking primary and secondary pharmacology mediated adverse effects as a path to increase likelihood of success in drug development. (20th October 2017) - Valentin, Jean-Pierre; Atienzar, Franck; Class, Reiner; Delaunois, Annie; Fleurance, Renaud; Gerets, Helga; Glineur, Stéphanie; Gryshkova, Vitalina; Hall, Peter; Hasselgren, Catrin; Tilmant, Karen